N Zone S (125+250) Injection | Price, Usage, Dosage, Composition, and Brand Substitutes - Fixed-Dose Combination (FDC) Drug
N Zone S (125+250) Injection
N Zone S (125+250) is a Fixed-Dose Combination (FDC) Drug Brand being manufactured and marketed by Aknil Biotech. This medicine is combination of more than one active ingredient or substance within a single pharmaceutical form type. The main active ingredients or salts in this drug are Ceftriaxone Sodium, Sulbactam. This drug comes in the form of Injection. The general packing available for this medicine consists of 1 Vial and is priced at Rs 45 (arround $0.63 US Dollar)| Generic (Salt) Combination : | (Ceftriaxone Sodium+ Sulbactam) |
| Pharma Company : | Aknil Biotech |
| Brand Label : | N Zone S (125+250) |
| Preparation Type : | Injection |
| Single Dose : | 1 Vial |
| Composition (Fixed-Dose Combination) : |
|
| Pack Size/Qty/Vol : | 1 Vial |
| Price Unit : | Rs 45 INR (arround $0.63 US Dollar) |
| Price Pack : | Rs 45 INR (arround $0.63 US Dollar) |
Drug details for N Zone S (125+250)
Usage: Why is this medication prescribed?
The main active ingredients or salts in N Zone S (125+250) are :
Ceftriaxone Sodium
Indication (Prescribed for or used as):
For more details on Ceftriaxone Sodium, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Ceftriaxone Sodium..
SulbactamIndication (Prescribed for or used as): Gonorrhoea. Mixed aerobic-anaerobic infections. Infections especially those acquired in the hospital.
For more details on Sulbactam, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Sulbactam..
N Zone S (125+250) Drug Brands Substitutes with similar Fixed-Dose Combination (FDC) :
There are 18 Fixed-Dose Combination (FDC) Drug Brands listed here as Substitutes for N Zone S (125+250), which have same Fixed-Dose Combination of active substances or ingredients (i.e. Ceftriaxone Sodium-250 mg Sulbactam-125 mg).Please note that one can request a doctor or pharmacist to substitute a FDC Brand Version of the prescribed FDC drug brand, if any. Fixed-Dose Combination Drugs are being increasingly used due to the benefit of the combined effects of active ingredients given together. However, it is necessary to investigate the possible benefits in the clinical situation against possible disadvantages for each fixed combination drug and for each dose of the fixed combination drug. Potential advantages of fixed combination drugs may also include the counteracting by one ingredient of an adverse reaction produced by another one, and simplification of therapy, leading to improved compliance.
| Brand | Price (Rs.) | Brand | Price (Rs.) |
| Acrocef-S (250+125) | 50 | Atcef SB (250+125) (Aton Biotech) | 40 |
| Basicef S (250+125) | 42.5 | Ciphone S (250+125) | 40 |
| Corcef SB (250+125) | 40 | Glen SB (250+125) | 45 |
| Incef SB (250+125) | 52 | Kafi S (250+125) | 45 |
| Keftragard (250+125) | 40 | Mahixon S (250+125) | 44 |
| Monobact (250+125) | 38.2 | Monobrite S (250+125) | 39.5 |
| Multixone S (250+125) | 57 | Simceff SB (250+125) | 46.9 |
| Spatrix SB (250+125mg) | 45 | Sulbacef (250+125) | 38 |
| Traxol O (250+125) | 40 | Zencef Plus (250+125) | 48 |